Quality of life and symptom treatment response in postmenopausal women with advanced breast cancer (ABC) receiving Fulvestrant after progression on prior antiestrogen therapy

被引：0
|
作者：
Kalyadina, S. [1 ]
Novik, A. [2 ]
Ionova, T. [1 ]
机构：
[1] Multinat Ctr Qual Life Res, St Petersburg, Russia
[2] Pirogov Natl Med Surg Ctr, Moscow, Russia
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70666-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 195
页数：1
相关论文
共 50 条
  • [41] Quality of Life (QoL) in Postmenopausal Breast Cancer Patients Receiving Adjuvant Hormonal Therapy
    Bichoo, Raouef Ahmed
    Mishra, Anjali
    Lal, Punita
    Gyan, Chand
    Agarwal, Gaurav
    Agarwal, Amit
    Mishra, Saroj Kanta
    INDIAN JOURNAL OF SURGERY, 2021, 83 (SUPPL 2) : 461 - 467
  • [42] FULVESTRANT ('FASLODEX'): A NEW OPTION FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE, ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN
    Kleeberg, Ulrich R.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3537 - 3537
  • [43] Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
    I. Blancas
    M. Fontanillas
    V. Conde
    J. Lao
    E. Martínez
    M. J. Sotelo
    A. Jaen
    J. L. Bayo
    F. Carabantes
    J. J. Illarramendi
    M. M. Gordon
    J. Cruz
    A. García-Palomo
    C. Mendiola
    E. Pérez-Ruiz
    J. S. Bofill
    J. M. Baena-Cañada
    N. M. Jáñez
    G. Esquerdo
    M. Ruiz-Borrego
    Clinical and Translational Oncology, 2018, 20 : 862 - 869
  • [44] Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
    Blancas, I.
    Fontanillas, M.
    Conde, V.
    Lao, J.
    Martinez, E.
    Sotelo, M. J.
    Jaen, A.
    Bayo, J. L.
    Carabantes, F.
    Illarramendi, J. J.
    Gordon, M. M.
    Cruz, J.
    Garcia-Palomo, A.
    Mendiola, C.
    Perez-Ruiz, E.
    Bofill, J. S.
    Baena-Canada, J. M.
    Janez, N. M.
    Esquerdo, G.
    Ruiz-Borrego, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (07) : 862 - 869
  • [45] QUALITY OF LIFE OF POSTMENOPAUSAL WOMEN WITH BREAST CANCER TREATED WITH ADJUVANT ENDOCRINE THERAPY
    Bellizzi, Keith M.
    Taxel, Pamela
    Dibble, Kate E.
    Siembida, Elizabeth J.
    Pescatello, Linda S.
    Schifano, Elizabeth D.
    Guarneri, Samantha
    Tannenbaum, Susan H.
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S1896 - S1896
  • [46] Symptom Clusters and Quality of Life in Patients With Breast Cancer Receiving Endocrine Therapy in China
    Jing, Feng
    Zhu, Zheng
    Qiu, Jiajia
    Tang, Lichen
    Xu, Lei
    Xing, Weijie
    Hu, Yan
    SEMINARS IN ONCOLOGY NURSING, 2023, 39 (04)
  • [47] ECONOMIC EVALUATION OF FULVESTRANT 500MG FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER WHO HAVE PROGRESSED ON ENDOCRINE THERAPY
    Polanco, A. C.
    Salazar, A.
    Soto, H.
    Pizarro, M.
    VALUE IN HEALTH, 2014, 17 (03) : A87 - A87
  • [48] Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - results from a compassionate use program.
    Petruzelka, L
    Zimovjanova, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 59S - 59S
  • [49] Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - updated results from an expanded access programme
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 171 - 171
  • [50] Multicenter observational study of fulvestrant 500 mg in postmenopausal Japanese women with ER positive advanced or recurrent breast cancer after prior endocrine treatment (SBCCSG29 study)
    Kimizuka, K.
    Inoue, K.
    Nagai, S.
    Saito, T.
    Nakano, S.
    Futsuhara, K.
    Sakurai, T.
    Yamada, H.
    Hata, S.
    Kaneko, S.
    Kurosumi, M.
    ANNALS OF ONCOLOGY, 2015, 26 : 18 - 18
12345